Mysterious New RNA Strands may Help Colon Cancer Cells Survive

New long strands of RNA called long non-coding RNAs (lincRNAs) have been found to assist colon cancer cells to avoid death, finds a new study. The findings of this study are published in the Scientific Reports journal. In a new study, researchers compared lincRNA levels inside tumor cells, to levels inside healthy colon cells. They found over 200 lincRNAs at significantly different levels inside the tumor cells as compared to normal cells. One, in particular, called lincDUSP, was overexpressed in 91 percent of the tumor samples. A few tumors had more than fifteen times the normal amount of lincDUSP. The significant increase suggested this mysterious, and previously uncharacterized, RNA could be cancer-causing.

"To determine whether lincDUSP shows oncogenic activity in colon cancer, we decided to test the effects of depleting lincDUSP in patient-derived colon tumor cell lines," wrote the authors. The researchers genetically modified colon cancer cells to deplete lincDUSP, and surprisingly, the cells began replicating at normal rates. They no longer had unrestricted growth associated with colon cancer tumor cells. Small molecules that inhibit lincDUSP, say the researchers, could have similar effects.

"Our work demonstrates that not only protein-coding genes but also non-coding genes contribute to colon cancer progression," says Ahmad Khalil, PhD, senior author, assistant professor of genetics and genome sciences at Case Western Reserve University School of Medicine, and member of the Case Comprehensive Cancer Center. "LincRNAs could be exploited as direct drug targets in this and other human diseases."

Khalil's team discovered that depleting lincDUSP restored inherent cell death mechanisms. Colon cancer cells with low levels of lincDUSP became susceptible to cellular checkpoints that keep growth in check. They immediately committed cell suicide--apoptosis--at the first sign of DNA damage.

Depleting the single lincRNA also had widespread genetic effects. Khalil's team discovered that reducing lincDUSP levels affected the expression of over 800 other genes. These results, combined with the team's experiments showing lincDUSP interacting with DNA, add to a growing body of evidence that lincRNAs are central to gene regulation. As such, they could represent an intriguing arena for drug developers.

"Not much is known about the role of long non-coding RNAs in colon cancer," says Khalil. "Using new technologies that target RNA molecules, instead of proteins, adds a new dimension to cancer therapies."

Source-Eurekalert